LOG 07 / QUESTIONS
DSIP questions, answered from the record
Direct, cited answers to the questions people most often ask about DSIP.
What are the benefits of DSIP peptide?
In the research record, DSIP's headline finding is enhancement of delta and spindle EEG activity, the brain waves of deep sleep, first shown in rabbits in 1977 [1]. Small 1980s human trials reported longer, less interrupted sleep in chronic insomniacs at 25 nmol/kg [2]. Community-reported benefits, which are anecdotal, include easier sleep onset and waking clear-headed. None is an approved benefit.
Does DSIP really work?
Inconsistently. Its delta-wave EEG effect is reproducible in animals [1], and small human trials reported modest sleep benefit [7], but a 2006 review called the sleep evidence extremely poorly documented and still weak, and noted no receptor has ever been found [3]. A large share of users report no effect at all. There is no large modern trial confirming it works.
How long does it take for DSIP peptide to work?
In the main human study, intravenous DSIP at 25 nmol/kg produced its sleep-promoting effect in the second hour after injection, with a slight arousal in the first hour [2]. This is a single small study, not a general timing rule, and timing is reported as unpredictable in community accounts. No reliable onset window has been established for any use.
How long does it take for DSIP to kick in?
The one detailed human study describes the sleep effect emerging in the second hour after an intravenous 25 nmol/kg dose, not immediately [2]. Community reports vary widely, with some describing effects that arrived hours late or even the next day. Because DSIP has a parabolic dose-response and a half-life of only minutes, onset is not predictable and has never been standardized.
Is DSIP habit forming?
There is no controlled study establishing whether DSIP is habit forming, because no large or long-term human safety trial exists [2]. The available human work is limited to small, short 1980s studies. Some community reports describe the benefit fading with nightly use, which points the other way from dependence, but addiction potential is genuinely uncharacterized, not established as absent.
What is the research dose of DSIP?
The most frequently used human research dose was 25 nmol/kg of body weight, given intravenously [2]. Animal studies used very different amounts by species, from fractions of a microgram in the rat brain to roughly 100 micrograms/kg in mice [5]. These are study parameters logged for documentation, not a recommended dose; DSIP has no approved or validated human dosing standard.
Where should you inject DSIP peptide?
This site does not provide administration instructions. In the published literature the routes studied were intravenous in humans and animals, intracerebroventricular and intranasal in rodents, and subcutaneous in cats and mice. These describe how researchers administered DSIP in studies. DSIP is an unapproved research chemical with no validated human delivery method or protocol.
What is a typical DSIP dosing protocol for research?
There is no standardized protocol. Human studies most often used a single intravenous 25 nmol/kg dose [2], while some used multi-injection courses such as a 10-injection clinical course [9]. Animal protocols varied widely by species and endpoint [5]. Because DSIP shows a parabolic dose-response and a minutes-long half-life with no validated human pharmacokinetics, no reliable protocol has ever been established.
Is DSIP safe to use long term?
Long-term safety is unknown. Human study is limited to small, mostly 1980s pilot trials and short experiments [2], with no large or long-duration controlled safety study and no validated human pharmacokinetic profile. Its mechanism has never been identified [3], so long-term effects and interactions cannot be predicted. Long-term safety should be treated as uncharacterized, not as established.
What is DSIP peptide?
DSIP is delta sleep-inducing peptide, an endogenous nonapeptide (the nine-amino-acid sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) first isolated in 1977 from the cerebral blood of sleeping rabbits and named for its ability to enhance slow-wave (delta) EEG activity [1]. It occurs naturally in mammals and has the International Nonproprietary Name Emideltide, but no Emideltide product has ever been approved or marketed.
What is DSIP peptide used for?
In research, DSIP has been studied for chronic insomnia [2], for effects on the stress (HPA) axis [4], on growth-hormone and pineal melatonin pathways [13], and, in animals, on lifespan and tumor incidence [5]. None of these is an approved use. DSIP has not been shown in modern controlled trials to treat insomnia or any sleep disorder and is not approved for any indication.
How does DSIP make you feel?
Reports vary and are anecdotal, not clinical evidence. Among people who respond, common descriptions are a quieter mind, easier sleep onset, deeper-feeling sleep, vivid dreams, and waking clear-headed. A large share report feeling nothing at all. The original human study notably reported no daytime sedation [2]. Because the mechanism is unknown [3], the subjective experience is genuinely unpredictable.
Does DSIP make you tired?
Not in the sedative sense for most reporters. The first detailed human study reported no daytime sedation and described DSIP as supporting sleep without a hangover effect [2]. Community accounts frame it as nudging an existing sleep drive rather than forcing sleep, though a minority report next-day grogginess. It is not consistently described as making people tired during the day.
Does DSIP work immediately?
No. In the main human study the sleep-promoting effect appeared in the second hour after an intravenous dose, not immediately, with a slight arousal in the first hour [2]. Community reports describe even more variable and sometimes delayed timing. There is no evidence of an immediate effect, and onset has never been reliably characterized for any route or use.
How long before bed should you take DSIP?
This site gives no timing instructions for use. As context, the one detailed human study saw the sleep effect emerge in the second hour after an intravenous dose [2], and community reports describe timing as unpredictable, sometimes hours late. With a parabolic dose-response and a minutes-long half-life and no validated human pharmacokinetics, no reliable pre-sleep timing has been established.
How long can you take DSIP for?
No duration has been validated. Human studies used short courses, from single injections to a 10-injection clinical course [9], and none assessed extended use. Some community reports describe the benefit fading with consecutive nightly use, which is why community discussion favors intermittent use, but there is no controlled evidence defining a safe or effective duration for any purpose.
How long does DSIP peptide stay in your system?
Not long in the bloodstream. A clearance study in dogs, monkeys, and rats reported plasma half-lives on the order of only a few minutes, attributed to rapid breakdown by enzymes and plasma proteins. There is no validated human pharmacokinetic profile, so how long it persists or acts in people specifically has not been formally established.
Does DSIP help you fall asleep?
Sometimes, inconsistently. Small human trials reported improved sleep, including shorter sleep latency versus placebo, but described the effect as modest [7], and the original study saw benefit emerge in the second hour rather than at sleep onset [2]. Many users report no effect. DSIP has not been shown in modern controlled trials to reliably help people fall asleep, and it is not an approved sleep aid.
What are the side effects of DSIP peptide?
Reported side effects are mostly mild. Older human studies and community accounts most often cite headache, with occasional nausea, dizziness, and unpredictable timing, including next-day grogginess in some [7]. These are scattered reports, not measured rates. The larger concern is the unknowns: no identified mechanism [3] and no long-term human safety data [2], so rarer or long-term effects cannot be ruled out.
Does DSIP affect growth hormone?
In rats, DSIP stimulated growth-hormone release through a dopaminergic pathway, but this did not carry over to humans, studies in women found no growth-hormone or prolactin effect. So the growth-hormone finding is a cross-species result that failed to replicate in people, and DSIP should not be assumed to raise growth hormone in humans based on the rodent data alone.
Does DSIP raise cortisol or affect stress hormones?
In one human study, intravenous DSIP at 25 nmol/kg significantly reduced plasma ACTH-like immunoreactivity for at least three hours while cortisol was unchanged [4], suggesting an effect on the stress (HPA) axis rather than a rise in cortisol. However, this early ACTH-lowering finding was not reproduced in later human HPA work, so DSIP's effect on stress hormones is reported but not confirmed.
Is DSIP neuroprotective?
There are suggestive animal findings, not human proof. In a 2024 study, a blood-brain-barrier-crossing DSIP fusion peptide restored melatonin, serotonin, and dopamine and increased hippocampal neuron density in insomnia-model mice, outperforming native DSIP [6]. Rat work also used DSIP in stroke models. These are animal results; no controlled human study has established DSIP as neuroprotective in people.